[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350711-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350711-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","novel-technologies-for-gastrointestinal-cancer-detection-a-systematic-review-and-meta-analysis-of-diagnostic-accuracy","Novel Technologies for Gastrointestinal Cancer Detection - A Systematic Review and Meta-Analysis of Diagnostic Accuracy","","Systematic review and meta-analysis evaluated novel approaches for detecting gastrointestinal (GI) cancers and focused on diagnostic accuracy in clinical settings. Searches of PubMed, EMBASE, Scopus, and the Cochrane Library were conducted on December 11, 2024 and updated June 2, 2025, including cohort and randomized studies (English, ≥300 participants) assessing incident GI cancer. From 9,604 records, 72 studies were included. Stool DNA testing with positive fecal immunochemical testing showed the best colorectal performance, while Q-Cancer, GALADUS, and an AI esophageal model performed best for specific cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/novel-technologies-for-gastrointestinal-cancer-detection-a-systematic-review-and-meta-analysis-of-diagnostic-accuracy/350711/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/novel-technologies-for-gastrointestinal-cancer-detection-a-systematic-review-and-meta-analysis-of-diagnostic-accuracy/350711.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What types of studies were included in this systematic review?","Question",{"text":63,"@type":64},"Cohort studies and randomized controlled studies, published in English, evaluating a novel diagnostic approach for incident GI cancer in clinical settings were included, with eligibility requiring at least 300 participants and reported diagnostic accuracy metrics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many studies and records were ultimately included?",{"text":68,"@type":64},"From 9,604 records screened, 72 studies were included across colorectal, upper GI, esophageal, gastric, pancreatic, and hepatocellular carcinoma.",{"name":70,"@type":61,"acceptedAnswer":71},"Which technologies showed the strongest diagnostic performance across cancer types?",{"text":72,"@type":64},"Stool DNA testing combined with a positive fecal immunochemical test performed best for colorectal cancer; Q-Cancer performed best for pancreatic cancer; the GALADUS model performed best for hepatocellular carcinoma in cirrhotic patients; and an artificial intelligence model performed best for esophageal cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350711,1790293725,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","REVIEW ARTICLE 1  \nNovel Technologies for Gastrointestinal Cancer Detection: A Systematic Review and Meta-Analysis of Diagnostic Accuracy  \nMelissa Barlow, PhD1 , Sarah Bailey, MPH, PhD1 , Saleh Alessy, MPH, PhD2 ,3 ,4 , Badr Al-Bawardy, MD5 ,6 ,7 , Sadeem Aldarweesh, MSc3 , Rowaedh A. Bawaked, PhD2 , Heba Alharith, BSc3 , Amin Mahdi, MD8 , Asrar Alaklabi, BSc3 , Mohammad Mawardi, MD9 ,  \nAldanah M. Althwanay, MD 10 , Nora A. Althumiri, PhD11 , Saleh Alabbad, MD12 , Khalid I. Bzeizi, MD12 , Severin Rakic, MD, PhD13 , Ahmed Allehebi, MD 14 , Predrag Zivotic, MD13 , Volkan Cetinkaya, PhD13 , Bandar AlJudaibi, MD12 and Saleh A. Alqahtani, MD3 , 12 , 15  \nINTRODUCTION: Gastrointestinal (GI) cancers account for a quarter of all cancers and one-third of cancer-related deaths worldwide. Novel diagnostic approaches are crucial to enhance early detection and improve patient outcomes. This review systematically identified and evaluated novel GI cancer detection approaches.  \nMETHODS: A systematic review was conducted using PubMed, EMBASE, Scopus, and the Cochrane Library on December 11, 2024, and updated on June 2, 2025. Cohort studies and randomized controlled studies, published in English, that evaluated a novel diagnostic approach for incident GI cancer in a clinical setting, included ‡300 participants, and reported diagnostic accuracy metrics were eligible for inclusion. Two reviewers independently screened studies and assessed risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2 tool.  \nRESULTS: Of 9,604 records screened, 72 studies were included: by site, 51 on colorectal, 1 on upper GI, 1 on esophageal,7on gastric,9 on pancreatic, and5on hepatocellular carcinoma. Stool DNAtesting inpatients with a positive fecal immunochemical test showed the highest performance for colorectal cancer (area under the receiver operating characteristic curve [AUC] 0.94–0.98). The best performing technologies across other cancer types were Q-Cancer for pancreatic (AUC 0.89–0.92), the GALADUS model for hepatocellular carcinoma in cirrhotic patients (AUC 0.94), and an artificial intelligence model for esophageal cancer (AUC 0.87) .  \nDISCUSSION: This review highlights several promising novel diagnostic approaches for GI cancer detection. External validation, population-level studies, and health economic evaluation are crucial to establish clinical utility across different settings and populations. Clinicians and policy makers must weigh the added value of novel technologies against current practice, regulatory requirements, clinical understanding, interpretation of results, and public trust.  \nKEYWORDS: gastrointestinal neoplasms; early cancer detection; diagnostic accuracy; cancer screening; biomarkers; artificial intelligence; fecal immunochemical test; systematic review and meta-analysis  \n1Department of Health and Community Sciences, University of Exeter, Exeter, UK; 2 Public Health Department, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia; 3Liver, Digestive, & Lifestyle Health Research Section, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; 4Faculty of Life Sciences and Medicine, Centre for Cancer, Society and Public Health, King’s College London, London, UK; 5College of Medicine, Al Faisal University, Riyadh, Saudi Arabia; 6Department of Internal Medicine, Division of Gastroenterology and Hepatology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 7Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA; 8Al Salama Hospital, Jeddah, Saudi Arabia; 9Department of Medicine, Gastroenterology Section, King Faisal Specialist Hospital & Research Center, Jeddah, Saudi Arabia; 10Division of Gastroenterology, Washington University in St. Louis, St. Louis, Missouri, USA; 11 Informed Decision Making, Riyadh, Saudi Arabia; 12Organ Transplant Center of Excellence, King Faisal Specialist Hospital","cbCaibJb59T2Z3Q9","https://ap.wps.com/l/cbCaibJb59T2Z3Q9","pdf",899003,"English","# Introduction\n# Methods\n# Results\n# Discussion\n# Keywords\n# Abbreviations","[{\"question\":\"What types of studies were included in this systematic review?\",\"answer\":\"Cohort studies and randomized controlled studies, published in English, evaluating a novel diagnostic approach for incident GI cancer in clinical settings were included, with eligibility requiring at least 300 participants and reported diagnostic accuracy metrics.\"},{\"question\":\"How many studies and records were ultimately included?\",\"answer\":\"From 9,604 records screened, 72 studies were included across colorectal, upper GI, esophageal, gastric, pancreatic, and hepatocellular carcinoma.\"},{\"question\":\"Which technologies showed the strongest diagnostic performance across cancer types?\",\"answer\":\"Stool DNA testing combined with a positive fecal immunochemical test performed best for colorectal cancer; Q-Cancer performed best for pancreatic cancer; the GALADUS model performed best for hepatocellular carcinoma in cirrhotic patients; and an artificial intelligence model performed best for esophageal cancer.\"}]","Novel Technologies for Gastrointestinal Cancer Detection - A Systematic Review and Meta-Analysis of Diagnostic Accuracy | PDF",1790090686,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c28a9e89a8b8f92ab62a55b6d55b485.webp",983,1296,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d240be29abbcd1d4465dd898d78239d5.webp",982,1294,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aaa08460c3d12922ea5e31f260c54c25.webp",981,1293,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41117f1bdce3eb40b39592f505c2a331.webp",980,1292]